But a new study suggests the drug may also provide a ... a common B vitamin previously recommended to lower cholesterol. The team ... Scientists Uncover a Crucial Link Between Cholesterol ...
High LDL cholesterol levels (“bad cholesterol”), low HDL cholesterol levels (“good cholesterol ... shown to also improve cardiovascular risk—the statins. PCSK9 inhibitor drugs, first approved for use ...
The Scottish Medicines Consortium (SMC) has rejected Daiichi Sankyo’s new cholesterol-lowering drug Nilemdo for use by NHS Scotland, saying the evidence backing the drug isn’t strong enough.
A new cholesterol-lowering drug called Nexletol has shown promise in reducing the risk of heart attacks and other cardiovascular problems in people who cannot tolerate traditional statin drugs, ...